The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
Open accessAbstract
Background— Lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) is expressed abundantly in the necrotic core of coronary lesions, and products of its enzymatic activity may contribute to inflammation and cell death, rendering plaque vulnerable to rupture. Methods and Results— This study compared the effects of 12 months of treatment with darapladib (an oral Lp-PLA 2 inhibitor, 160 mg daily) or placebo on coronary atheroma deformability (intravascular ultrasound palpography) and plasma high-sensitivity C-reactive protein in 330 patients with angiographically documented coronary disease. Secondary end points included changes in necrotic core size (intravascular ultrasound radiofrequency), atheroma size (intravascular ultrasound gray scale), and blood biomarkers. Background therapy was comparable between groups, with no difference in low-density lipoprotein cholesterol at 12 months (placebo, 88±34 mg/dL; darapladib, 84±31 mg/dL; P =0.37). In contrast, Lp-PLA 2 activity was inhibited by 59% with darapladib ( P <0.001 versus placebo). After 12 months, there were no significant differences between groups in plaque deformability ( P =0.22) or plasma high-sensitivity C-reactive protein ( P =0.35). In the placebo-treated group, however, necrotic core volume increased significantly (4.5±17.9 mm 3 ; P =0.009), whereas darapladib halted this increase (−0.5±13.9 mm 3 ; P =0.71), resulting in a significant treatment difference of −5.2 mm 3 ( P =0.012). These intraplaque compositional changes occurred without a significant treatment difference in total atheroma volume ( P =0.95). Conclusions— Despite adherence to a high level of standard-of-care treatment, the necrotic core continued to expand among patients receiving placebo. In contrast, Lp-PLA 2 inhibition with darapladib prevented necrotic core expansion, a key determinant of plaque vulnerability. These findings suggest that Lp-PLA 2 inhibition may represent a novel therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries
Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R., & Kolettis, G. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162204 · Cited by 3,623
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Brown, B. G., Ganz, P., Vogel, R. A., Crowe, T., Howard, G., Cooper, C. J., Brodie, B., et al. (2004) · JAMA · doi:10.1001/jama.291.9.1071 · Cited by 2,361
Self-citationNissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047
Angiographic progression of coronary artery disease and the development of myocardial infarction
Ambrose, J. A., Tannenbaum, M. A., Alexopoulos, D., Hjemdahl-Monsen, C. E., Leavy, J., Weiss, M., Borrico, S., Gorlin, R., & Fuster, V. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90356-7 · Cited by 1,452
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis
Nair, A., Kuban, B. D., Tuzcu, E. M., Schoenhagen, P., Nissen, S. E., & Vince, D. G. (2002) · Circulation · doi:10.1161/01.cir.0000035654.18341.5e · Cited by 1,129
Self-citationTabas, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000184783.04864.9f · Cited by 641
Accuracy of In Vivo Coronary Plaque Morphology Assessment
Nasu, K., Tsuchikane, E., Katoh, O., Vince, D. G., Virmani, R., Surmely, J.-F., Murata, A., Takeda, Y., Ito, T., Ehara, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.044 · Cited by 496
Self-citationZalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
Self-citationOei, H.-H. S., van der Meer, I. M., Hofman, A., Koudstaal, P. J., Stijnen, T., Breteler, M. M. B., & Witteman, J. C. M. (2005) · Circulation · doi:10.1161/01.cir.0000154553.12214.cd · Cited by 423
Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tuzcu, E. M., Brewer, H. B., Sipahi, I., Nicholls, S. J., Ganz, P., Schoenhagen, P., Waters, D. D., Pepine, C. J., Crowe, T. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054699 · Cited by 398
Self-citationMacphee, C. H., Moores, K., Boyd, H., Dhanak, D., Ife, R. J., Leach, C. A., Leake, D. S., Milliner, K. J., Patterson, R. A., Suckling, K. E., et al. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380479 · Cited by 359
Nair, A., Mp, M., Kuban, B. D., & Vince, D. G. (2007) · PubMed · Cited by 320
Self-citationKolodgie, F. D., Burke, A. P., Skorija, K. S., Ladich, E., Kutys, R., Makuria, A. T., & Virmani, R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000244681.72738.bc · Cited by 309
Lavi, S., McConnell, J. P., Rihal, C. S., Prasad, A., Mathew, V., Lerman, L. O., & Lerman, A. (2007) · Circulation · doi:10.1161/circulationaha.106.671420 · Cited by 229
O’Donoghue, M., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Cannon, C. P., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.612630 · Cited by 229
Mohler, E. R., Ballantyne, C. M., Davidson, M. H., Hanefeld, M., Ruilope, L. M., Johnson, J. L., & Zalewski, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.079 · Cited by 209
Self-citationKoenig, W., Twardella, D., Brenner, H., & Rothenbacher, D. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000222983.73369.c8 · Cited by 204
Kinlay, S., Schwartz, G. G., Olsson, A. G., Rifai, N., Sasiela, W. J., Szarek, M., Ganz, P., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000136588.62638.5e · Cited by 171
Self-citationDiethrich, E. B., Margolis, M. P., Reid, D. B., BURKE, A. P., Ramaiah, V. G., Rodriguez‐Lopez, J. A., Wheatley, G. H., Olsen, D. M., & Virmani, R. (2007) · Journal of Endovascular Therapy · doi:10.1177/152660280701400512 · Cited by 162
Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses
Shi, Y., Zhang, P., Zhang, L., Osman, H. E., Mohler, E. R., Macphee, C. H., Zalewski, A. A., Postle, A. D., & Wilensky, R. L. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.001 · Cited by 136
Self-citationvan Mieghem, C. A. G., McFadden, E. P., de Feyter, P. J., Bruining, N., Schaar, J. A., Mollet, N. R., Cademartiri, F., Goedhart, D. M., de Winter, S., Rodríguez-Granillo, G. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.075 · Cited by 121
Self-citationCarpenter, K. L. H., Dennis, I. F., Challis, I. R., Osborn, D. P., Macphee, C. H., Leake, D. S., Arends, M. J., & Mitchinson, M. J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02840-x · Cited by 114
Davis, B., Koster, G., Douet, L., Ščigelová, M., Woffendin, G., Ward, J. M., Smith, A., Humphries, J., Burnand, K. G., Macphee, C. H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m709970200 · Cited by 105
Development of Systems of Care for ST-Elevation Myocardial Infarction Patients
Mensah, G. A., Hand, M. M., Antman, E. M., Ryan, T. J., Schriever, R., & Smith, S. C. (2007) · Circulation · doi:10.1161/circulationaha.107.184045 · Cited by 32
Cited by
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
Atherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Libby, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1216063 · Cited by 1,262
Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Metadata
- Authors
- Serruys, P. W., García-García, H. M., Buszman, P., Erne, P., Verheye, S., Aschermann, M., Duckers, H., Bleie, O., Dudek, D., Bøtker, H. E., von Birgelen, C., D'Amico, D., Hutchinson, T., Zambanini, A., Mastik, F., van Es, G.-A., van der Steen, A. F. W., Vince, D. G., Ganz, P., Hamm, C. W., Wijns, W., & Zalewski, A.
- Venue
- Circulation
- Published
- 2008-09-09
- Volume
- 118
- Issue
- 11
- Pages
- 1172-1182
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2110551379
- Cited by
- 505
- References
- 26
- FWCI
- 62.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.